For instance, a higher expression of MDM2 was observed in younger women with breast cancer [44], whereas Adami and colleagues reported positive effects of female sex hormones on the incidence of lung cancer in women receiving hormone replacement therapy, particularly in those with a history of smoking [45]. Here, MDM2 is linked to breast cancer.